However, our in vivo results using both shRNA and pharmacological agents tend to confirm that BMX depletion/inhibition within a complex tumor ecosystem still leads to substantial decrease in tumor growth, supporting the translational relevance of our findings. The gene discussed is BMX; the disease is neoplasm.